Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation versus interruption of oral anticoagulation during TAVI
NL-OMON56111Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in aortic stenosis (AS) and Atrial fibrillation (AFib) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary composite endpoint. Started Nov 2020; status: completed.
02
Conditions
aortic stenosis (AS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON56111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56111.